• 30
  • June
    2011

Multi-Mex Distributor is pulling yet more products from the shelves of a handful of states due to the mix-up of the company's dietary supplements with one of the company's over-the-counter antibiotics, according to the Food and Drug Administration (FDA). The removal comes after the distributor pulled the product from shelves in Texas stores.

After not seeing marked recovery, four Texas children were taken to the hospital. It was discovered that parents of the children had been treating the children's illnesses with Amoxilina, a Multi-Mex product, under the mistaken assumption that the product was Amoxil, an over-the-counter antibiotic available in Mexico.

Following the trips to the hospital, the Texas Attorney General filed a lawsuit against Multi-Mex for unlawfully marketing and dispensing its product. Texas authorities said that the packaging of the dietary supplement Amoxilina intentionally mimics - same color scheme and box design - that of Amoxil, an antibiotic to treat ear and throat infections readily available in Mexico.

The incident in Texas prompted the FDA to open its own investigation, which has resulted in Multi-Mex pulling a total of eight products, in several dosages, from stores in Georgia, Tennessee, California, Illinois, Texas, North Carolina, South Carolina, Colorado and Indiana.

According to the FDA, the products, labeled in both English and Spanish, "appear to be an intentional marketing ploy to mimic antibiotics and directed at Hispanic buyers."

The FDA noted that the easily mistaken products could lead to doctors to "over-medicate" or order unnecessary medical procedures.

If you have any of the recalled products, return the products to the place of purchase for a full refund. If the easily mistaken packaging has led to any adverse side-effects or injuries, speak with an experienced personal injury attorney.